Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.36 |
| ▸ | C1S | P09871 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12514329 | 0.88 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2HPGDADRB1DDB1 | |
| SCHEMBL12787331 | 0.86 | SIGMAR1 (0.41) | ALDH1A1SMN1; SMN2DDB1CRBNMAPT | |
| SCHEMBL16711539 | 0.81 | MAPT (0.43) | ALDH1A1SMN1; SMN2HPGDADRB1DDB1 | |
| SCHEMBL18964726 | 0.80 | NPC1 (0.48) | ALDH1A1SMN1; SMN2HPGDMAPTNPC1 | |
| SCHEMBL22447052 | 0.74 | SIGMAR1 (0.52) | ALDH1A1ADRB1DDB1CRBNMAPT | |
| SCHEMBL12153468 | 0.73 | SIGMAR1 (0.48) | SMN1; SMN2HPGDDDB1CRBNMAPT | |
| SCHEMBL30261935 | 0.73 | SIGMAR1 (0.48) | SMN1; SMN2HPGDDDB1CRBNMAPT | |
| SCHEMBL24526126 | 0.73 | NOS3 (0.37) | ALDH1A1SMN1; SMN2HPGDDDB1CRBN | |
| SCHEMBL18532156 | 0.72 | SMN1; SMN2 (0.37) | ALDH1A1SMN1; SMN2HPGDADRB1DDB1 | |
| SCHEMBL45191 | 0.72 | SIGMAR1 (0.43) | ALDH1A1SMN1; SMN2HPGDDDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9284278-B2 | Electroluminescent metal complex | BASF SE (DE) | 2016-03-15 | — | — | US | disclosed |
| US-8734963-B2 | Complex salts | BASF SE (DE) | 2014-05-27 | — | — | US | disclosed |
| EP-2139907-B1 | ELECTROLUMINESCENT METAL COMPLEX | BASF SE (DE) | 2013-08-14 | — | — | EP | disclosed |
| EP-2337786-B1 | COMPLEX SALTS | BASF SE (DE) | 2013-08-14 | — | — | EP | disclosed |
| US-20110177630-A1 | COMPLEX SALTS | BASF SE (DE) | 2011-07-21 | — | — | US | disclosed |
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | CIBA CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | CIBA CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
| WO-2009087064-A1 | ELECTROLUMINESCENT IONIC HOST-GUEST DENDRITIC MATERIALS | BASF SE (DE) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | LDHA, LDHB, NRP1 | ALDH1A1 233/4885SMN1; SMN2 1608/4885HPGD 2388/4885 |
| US-20110177630-A1 | COMPLEX SALTS | NCLN, AP3M1, AP2M1 | ALDH1A1 3608/4885SMN1; SMN2 3511/4885HPGD 4661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.